Cytogen completes Cellcor purchase
November 8, 1995
Monoclonal antibody firm Cytogen of Princeton, NJ, has completedits purchase of Cellcor, a biotech therapy developer based inNewton, MA (SCAN 7/19/95). Cellcor has been merged into Cytogenas a wholly owned subsidiary, Cytogen
Monoclonal antibody firm Cytogen of Princeton, NJ, has completedits purchase of Cellcor, a biotech therapy developer based inNewton, MA (SCAN 7/19/95). Cellcor has been merged into Cytogenas a wholly owned subsidiary, Cytogen said.